Sight Sciences (SGHT) | Stock Overview & Key Data
Sight Sciences Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $42.57 on August 2, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sight Sciences
SGHT
|
237.20M Micro-cap | 8.42% | 0.80% | 34.22% | -39.59% | -32.89% | 24.21% | -39.50% | -84.31% | -84.31% | -84.31% | -84.31% |
| 160.70B Large-cap | -2.02% | 4.97% | -19.35% | -30.98% | -28.60% | -34.98% | -16.97% | -20.08% | 135.84% | 255.56% | 329.52% | |
|
Stryker
SYK
|
126.25B Large-cap | 2.13% | 0.38% | -11.91% | -13.33% | -11.56% | -17.25% | 6.06% | 22.47% | 172.95% | 440.98% | 592.85% |
|
Monogram
MGRM
|
244.21M Micro-cap | 1.69% | 4.35% | 81.82% | 151.05% | 138.10% | 157.51% | -55.56% | -55.56% | -55.56% | -55.56% | -55.56% |
|
Nevro
NVRO
|
224.09M Micro-cap | N/A | N/A | N/A | N/A | N/A | -56.06% | -92.38% | -94.65% | -89.12% | -76.92% | -76.92% |
|
Electromed
ELMD
|
212.52M Micro-cap | 0.97% | 4.93% | 57.38% | 26.49% | 36.69% | 85.05% | 216.89% | 234.59% | 821.59% | 1,002.08% | 833.17% |
Ownership & Short Interest
Calculate Your Sight Sciences Investment Returns
Long-Term Investment Performance Analysis
Sight Sciences stock price in Jul 2021 was $32.70, A $1,000.00 lump sum investment in Sight Sciences made 4 years ago would be worth approximately $153.52 today, representing a negative return of -84.65%. This translates to an annualized return (CAGR) of -31.65%.
4 Years 11 Months Investment Scenario (Jul 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SGHT's 52-week high and low?
- In the last 52 weeks, Sight Sciences reached a high of $9.24 (on December 26, 2025) and a low of $3.11 (on August 1, 2025).
- What is the market cap and P/E ratio for SGHT?
- Curious about Sight Sciences's size and valuation? Its market capitalization stands at 237.20M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -7.85.
- Does SGHT pay dividends? If so, what's the yield?
- As for dividends, Sight Sciences isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Sight Sciences's main competitors or similar companies to consider before investing?
When looking at Sight Sciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT160.70B Healthcare Medical Devices -34.98% -16.97% Stryker
SYK126.25B Healthcare Medical Devices -17.25% 6.06% Monogram
MGRM244.21M Healthcare Medical Devices 157.51% -55.56% Nevro
NVRO224.09M Healthcare Medical Devices -56.06% -92.38% Electromed
ELMD212.52M Healthcare Medical Devices 85.05% 216.89% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Sight Sciences Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Sight Sciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -50.74%, the Debt to Equity ratio from the most recent quarter is 63.77, and its Gross Profit Margin stands at 87.26%.
- What is the recent revenue and earnings growth for SGHT?
- Looking at Sight Sciences's growth, its revenue over the trailing twelve months (TTM) was $77M. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.90%, and quarterly earnings saw a YoY growth of 6.87%.
- How much of SGHT stock is held by insiders and institutions?
- Wondering who owns Sight Sciences stock? Company insiders (like executives and directors) hold about 20.96% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 48.49%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.